Answers are grounded in this paper and cite their sources.
To study the effectiveness of corneal collagen cross linking with riboflavin and ultraviolet-A light for keratoconus in Iraqi patients. Fifty four eyes of 27 patients with progressive keratoconus were studied in this prospective study. All eyes included in this study completed a follow up period of 6 months. Preoperative assessment of uncorrected visual acuity, best corrected visual acuity (BCVA), corneal topography using the pentacam, and Pachymetry were done and these tests were repeated at each postoperative visit. 9 male and 18 female patients were studied. The mean age was 24.9 ±5.35 (range 9-37 years) and the mean follow-up was 7.3 months. The preoperative values were compared with postoperative values. The BCVA improved at least one line in 55.5% (30 eyes) of eyes. 44.5% (24 eyes) showed stable BCVA (P< 0.001). The steepest corneal curvature was decreased by a mean of 1.74 Diopters ± 1.18 (D) in the total population studied. It was decreased by a mean of 2.04 Diopters ± 0.76 in 79.6% (43 eyes) (P<0.003) and remained stable (within ± 0.50 D) in 20.4% (11 eyes) of eyes. Corneal collagen cross linking with riboflavin and UVA light is effective treatment for progressive keratoconus in Iraqi patients
No takes yet. Share an insight, caveat, or question.
حسن et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: